Skip to main content
. 2016 Apr;97(4):596–603. doi: 10.1016/j.apmr.2015.12.018

Table 1.

CRF and functional outcome measures at baseline and 19wk for exercise and control groups

Variable Exercise Group (n=20)
Control Group (n=20)
Group × Time (95% Confidence Interval)
Baseline 19wk Δ P Baseline 19wk Δ P
Cardiorespiratory measures
 Peak oxygen consumption (mL/(kg⋅min)) 18±5 21±5 3 <.01 18±5 18±5 0 .62 <.01 (1.3 to 5.2)
 Peak work rate (W) 112±36 121±37 9 <.01 105±34 101±35 −4 .13 <.01 (0.1 to 0.3)
 Peak arterial-venous oxygen difference (mL of O2/100mL of blood) 9.2±2.7 11.4±2.9 2.2 <.01 9.1±2.4 10.1±3.0 1 <.05 0.09 (−0.2 to 2.5)
 Peak cardiac output (L/min) 17.2±4 17.7±4.2 0.5 .44 16.2±2.9 15.8± 2.6 −0.4 .26 0.23 (−0.5 to 2.1)
 Peak cardiac power output (W) 4.8±1.3 5.0±1.35 0.2 .45 4.6±0.93 4.2±1.4 −0.5 .1 0.145 (−0.1 to 0.9)
 Baseline cardiac output (L/min) 5.6±1.2 5.54±1.4 −0.1 .93 5.8±0.8 5.42±0.8 −0.4 .03 0.12 (−0.1 to 0.9)
 Baseline cardiac power output (W) 1.26±0.4 1.26±0.4 0 .91 1.29±0.2 1.25±0.2 −0.0 .36 0.6 (−0.1 to 0.18)
Physical performance
 6MWT distance (m) 428±131 513±131 85 <.01 419±127 441±126 22 <.05 <.01 (42 to 86)
 10MWT speed (m/s) 1.2±0.4 1.5±0.3 0.3 <.01 1.2±0.3 1.3±0.3 0.1 .01 <.01 (0.1 to 0.3)
 TUG test score (s) 11±9 8.4±6 −2.6 <.01 9.8±5 9±5 −0.8 .06 <.05 (−3.5 to −2.4)
 BBS score 50±4 55±2 5 <.01 50±5.6 52±5 2 <.05 <.01 (0.9 to 5)

NOTE. Values are mean ± SD or as otherwise indicated. Group x time indicates between group differences using change scores (significance and confidence intervals).

Abbreviation: Δ, change score.

P<.01.

P<.05.